Annual CFF
$10.36 M
+$11.98 M+736.12%
December 31, 2023
Summary
- As of February 7, 2025, ABCL annual cash flow from financing activities is $10.36 million, with the most recent change of +$11.98 million (+736.12%) on December 31, 2023.
- During the last 3 years, ABCL annual CFF has fallen by -$673.30 million (-98.49%).
- ABCL annual CFF is now -98.49% below its all-time high of $683.65 million, reached on December 31, 2020.
Performance
ABCL Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$3.15 M
+$494.00 K+18.63%
September 30, 2024
Summary
- As of February 7, 2025, ABCL quarterly cash flow from financing activities is $3.15 million, with the most recent change of +$494.00 thousand (+18.63%) on September 30, 2024.
- Over the past year, ABCL quarterly CFF has increased by +$494.00 thousand (+18.63%).
- ABCL quarterly CFF is now -99.48% below its all-time high of $609.94 million, reached on December 31, 2020.
Performance
ABCL Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$12.39 M
-$3.48 M-21.95%
September 30, 2024
Summary
- As of February 7, 2025, ABCL TTM cash flow from financing activities is $12.39 million, with the most recent change of -$3.48 million (-21.95%) on September 30, 2024.
- Over the past year, ABCL TTM CFF has dropped by -$3.48 million (-21.95%).
- ABCL TTM CFF is now -98.19% below its all-time high of $683.65 million, reached on December 31, 2020.
Performance
ABCL TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
ABCL Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +736.1% | +18.6% | -21.9% |
| 3 y3 years | -98.5% | +250.2% | -98.0% |
| 5 y5 years | -15.0% | - | - |
ABCL Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +366.5% | -52.6% | +200.4% | -21.9% | +326.4% |
| 5 y | 5-year | -98.5% | +366.5% | -99.5% | +121.9% | -98.2% | +326.4% |
| alltime | all time | -98.5% | +366.5% | -99.5% | +121.9% | -98.2% | +326.4% |
AbCellera Biologics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $3.15 M(+18.6%) | $12.39 M(-21.9%) |
| Jun 2024 | - | $2.65 M(-6.4%) | $15.88 M(+16.4%) |
| Mar 2024 | - | $2.83 M(-24.8%) | $13.64 M(+31.8%) |
| Dec 2023 | $10.36 M(-736.1%) | $3.77 M(-43.2%) | $10.36 M(+49.2%) |
| Sep 2023 | - | $6.63 M(+1482.3%) | $6.94 M(+2284.9%) |
| Jun 2023 | - | $419.00 K(-191.5%) | $291.00 K(-72.2%) |
| Mar 2023 | - | -$458.00 K(-231.2%) | $1.04 M(-164.2%) |
| Dec 2022 | -$1.63 M | $349.00 K(-1936.8%) | -$1.63 M(+1038.5%) |
| Sep 2022 | - | -$19.00 K(-101.6%) | -$143.00 K(-118.5%) |
| Jun 2022 | - | $1.17 M(-137.5%) | $774.00 K(-114.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$3.13 M(-270.7%) | -$5.47 M(+40.9%) |
| Dec 2021 | -$3.89 M(-100.6%) | $1.83 M(+104.2%) | -$3.89 M(-100.6%) |
| Sep 2021 | - | $898.00 K(-117.7%) | $604.22 M(+2.6%) |
| Jun 2021 | - | -$5.08 M(+228.9%) | $588.95 M(-0.9%) |
| Mar 2021 | - | -$1.54 M(-100.3%) | $594.37 M(-13.1%) |
| Dec 2020 | $683.65 M(>+9900.0%) | $609.94 M(-4344.5%) | $683.65 M(+827.4%) |
| Sep 2020 | - | -$14.37 M(-4253.2%) | $73.71 M(-16.3%) |
| Jun 2020 | - | $346.00 K(-99.6%) | $88.08 M(+0.4%) |
| Mar 2020 | - | $87.74 M | $87.74 M |
| Dec 2019 | $195.00 K(-98.4%) | - | - |
| Dec 2018 | $12.19 M | - | - |
FAQ
- What is AbCellera Biologics annual cash flow from financing activities?
- What is the all time high annual CFF for AbCellera Biologics?
- What is AbCellera Biologics annual CFF year-on-year change?
- What is AbCellera Biologics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for AbCellera Biologics?
- What is AbCellera Biologics quarterly CFF year-on-year change?
- What is AbCellera Biologics TTM cash flow from financing activities?
- What is the all time high TTM CFF for AbCellera Biologics?
- What is AbCellera Biologics TTM CFF year-on-year change?
What is AbCellera Biologics annual cash flow from financing activities?
The current annual CFF of ABCL is $10.36 M
What is the all time high annual CFF for AbCellera Biologics?
AbCellera Biologics all-time high annual cash flow from financing activities is $683.65 M
What is AbCellera Biologics annual CFF year-on-year change?
Over the past year, ABCL annual cash flow from financing activities has changed by +$11.98 M (+736.12%)
What is AbCellera Biologics quarterly cash flow from financing activities?
The current quarterly CFF of ABCL is $3.15 M
What is the all time high quarterly CFF for AbCellera Biologics?
AbCellera Biologics all-time high quarterly cash flow from financing activities is $609.94 M
What is AbCellera Biologics quarterly CFF year-on-year change?
Over the past year, ABCL quarterly cash flow from financing activities has changed by +$494.00 K (+18.63%)
What is AbCellera Biologics TTM cash flow from financing activities?
The current TTM CFF of ABCL is $12.39 M
What is the all time high TTM CFF for AbCellera Biologics?
AbCellera Biologics all-time high TTM cash flow from financing activities is $683.65 M
What is AbCellera Biologics TTM CFF year-on-year change?
Over the past year, ABCL TTM cash flow from financing activities has changed by -$3.48 M (-21.95%)